R452P (p.Arg452Pro) variant of MEN1 (Menin)
R452P (p.Arg452Pro) in MEN1 (Menin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Hereditary cancer-predisposing syndrome; not provided; Multiple endocrine neopla. The available variant effect predictions contribute to a CATVariant prioritization score of 0.79 / 1. The record also includes population frequency data, published literature, and structural context.
R452P (p.Arg452Pro) variant details
- p.Arg452Pro
- rs775922507
- ClinGen CA381179936
- ClinVar RCV000571203
- ClinVar RCV001377802
- Likely pathogenic
- Hereditary cancer-predisposing syndrome; not provided; Multiple endocrine neopla
- Missense
- Variant Prioritization Score for Impact Estimate 0.794
- AlphaMissense 0.19
- MetaLR 0.98
- MetaSVM 1.03
- CADD 28.30
- PolyPhen-2 0.99
- SIFT 0.01
- ClinVar: Likely pathogenic (Hereditary cancer-predisposing syndrome; not provided; Multiple)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Most common in the Non-Finnish European population (allele frequency 9e-07)
- Structural context available
- Cited in: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic… (PMID 25394175)
- Cited in: Guidelines for diagnosis and therapy of MEN type 1 and type 2. (PMID 11739416)